Masataka Hikota
Mitsubishi Tanabe Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Masataka Hikota.
Bioorganic & Medicinal Chemistry Letters | 2014
Toshiaki Sakamoto; Yuichi Koga; Masataka Hikota; Kenji Matsuki; Michino Murakami; Kohei Kikkawa; Kotomi Fujishige; Jun Kotera; Kenji Omori; Hiroshi Morimoto; Koichiro Yamada
Novel pyrimidine-5-carboxamide derivatives bearing a 3-chloro-4-methoxybenzylamino group at the 4-position were identified as potent and highly selective phosphodiesterase 5 inhibitors. Among them, we successfully found 10j (avanafil) which exhibited a potent relaxant effect on isolated rabbit cavernosum (EC30=2.1 nM) and a high isozyme selectivity.
Bioorganic & Medicinal Chemistry Letters | 2014
Toshiaki Sakamoto; Yuichi Koga; Masataka Hikota; Kenji Matsuki; Michino Murakami; Kohei Kikkawa; Kotomi Fujishige; Jun Kotera; Kenji Omori; Hiroshi Morimoto; Koichiro Yamada
5-(3,4,5-Trimethoxybenzoyl)-4-amimopyrimidine derivatives were found as a novel chemical class of potent and highly selective phosphodiesterase 5 inhibitors. A pseudo-ring formed by an intramolecular hydrogen bond constrained the conformation of 3-chloro-4-methoxybenzylamino and 3,4,5-trimethoxybenzoyl substituents and led to the discovery of T-6932 (19a) with a potent PDE5 inhibitory activity (IC50 = 0.13 nM) and a high selectivity over PDE6 (IC50 ratio: PDE6/PDE5 = 2400). Further modification at the 2-position of T-6932 resulted in the finding of 26, which exhibited potent relaxant effects on isolated rabbit corpus cavernosum (EC30 = 11 nM) with a high PDE5 selectivity over PDE6 (IC50 ratio: PDE6/PDE5 = 2800).
Bioorganic & Medicinal Chemistry Letters | 2015
Toshiaki Sakamoto; Yuichi Koga; Masataka Hikota; Kenji Matsuki; Hideki Mochida; Kohei Kikkawa; Kotomi Fujishige; Jun Kotera; Kenji Omori; Hiroshi Morimoto; Koichiro Yamada
A novel series of highly selective phosphodiesterase 5 (PDE5) inhibitors was found. 8H-Pyrido[2,3-d]pyrimidin-7-one derivatives bearing an (S)-2-(hydroxymethyl)pyrrolidin-1-yl group at the 2-position and a 3-chloro-4-methoxybenzyl group at the 8-position exhibited potent PDE5 inhibitory activities and high PDE5 selectivity over PDE6. Among the synthesized compounds, the 5-methyl analogue (5b) showed the most potent relaxant effect on isolated rabbit corpus cavernosum with an EC30 value of 0.85 nM.
Archive | 2001
Kosuke Yasuda; Hiroshi Morimoto; Saburo Kawanami; Masataka Hikota; Takeshi Matsumoto; Kenji Arakawa
Archive | 2001
Kosuke Yasuda; Hiroshi Morimoto; Saburo Kawanami; Masataka Hikota; Takeshi Matsumoto; Kenji Arakawa
Archive | 2004
Kosuke Yasuda; Hiroshi Morimoto; Saburo Kawanami; Masataka Hikota; Takeshi Matsumoto; Kenji Arakawa
Archive | 2001
Kosuke Yasuda; Hiroshi Morimoto; Saburo Kawanami; Masataka Hikota; Takeshi Matsumoto; Kenji Arakawa
Archive | 2002
Koichiro Yamada; Masataka Hikota; Yuichi Koga; Kohei Kikkawa; Kenji Omori
Archive | 2006
Kosuke Yasuda; Hiroshi Morimoto; Saburo Kawanami; Masataka Hikota; Takeshi Matsumoto; Kenji Arakawa
Archive | 2006
Naoyuki Harada; Masataka Hikota